{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:50:25Z","timestamp":1784055025171,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["FDCT 0148\/2022\/A3"],"award-info":[{"award-number":["FDCT 0148\/2022\/A3"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013098","name":"Scientific and Innovative Action Plan of Shanghai","doi-asserted-by":"publisher","award":["18431902800"],"award-info":[{"award-number":["18431902800"]}],"id":[{"id":"10.13039\/501100013098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013098","name":"Scientific and Innovative Action Plan of Shanghai","doi-asserted-by":"publisher","award":["20S11901600"],"award-info":[{"award-number":["20S11901600"]}],"id":[{"id":"10.13039\/501100013098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110951","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T09:32:42Z","timestamp":1694856762000},"page":"110951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PB","title":["A collagen-binding SIRP\u03b1Fc fusion protein for targeted cancer immunotherapy"],"prefix":"10.1016","volume":"124","author":[{"given":"Jiayang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-8548","authenticated-orcid":false,"given":"Tongyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudelaidi","family":"Kuerban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-6024","authenticated-orcid":false,"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.110951_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global Cancer Incidence and Mortality Rates and Trends\u2013An Update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/SPC.0000000000000171","article-title":"The last days of life: symptom burden and impact on nutrition and hydration in cancer patients","volume":"9","author":"Hui","year":"2015","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1087-0024.2000.00003.x","article-title":"Tumor angiogenesis","volume":"5","author":"Detmar","year":"2000","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2023.110951_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.intimp.2023.110951_b0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.intimp.2023.110951_b0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","article-title":"Why are tumour blood vessels abnormal and why is it important to know?","volume":"100","author":"Nagy","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110951_b0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"issue":"487","key":"10.1016\/j.intimp.2023.110951_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3259","article-title":"Targeted antibody and cytokine cancer immunotherapies through collagen affinity","volume":"11","author":"Ishihara","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0050","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ajpath.2013.06.026","article-title":"Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression","volume":"183","author":"Mammoto","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.110951_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","article-title":"Targeting the microenvironment in solid tumors","volume":"65","author":"Belli","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2023.110951_b0060","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.7150\/jca.18466","article-title":"Reorganized Collagen in the Tumor Microenvironment of Gastric Cancer and Its Association with Prognosis","volume":"8","author":"Zhou","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2023.110951_b0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","article-title":"Emerging roles of ECM remodeling processes in cancer","volume":"62","author":"Mohan","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0070","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jor.23756","article-title":"Novel protein therapeutic joint retention strategy based on collagen-binding Avimers","volume":"36","author":"Hulme","year":"2018","journal-title":"J. Orthop. Res."},{"issue":"498","key":"10.1016\/j.intimp.2023.110951_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2614","article-title":"Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy","volume":"11","author":"Momin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2023.110951_b0080","article-title":"A SIRP\u03b1Fc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-16-1700","article-title":"TTI-621 (SIRP\u03b1Fc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding","volume":"23","author":"Petrova","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.110951_b0090","doi-asserted-by":"crossref","first-page":"e0187262","DOI":"10.1371\/journal.pone.0187262","article-title":"TTI-621 (SIRP\u03b1Fc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110951_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103014","article-title":"CD47: the next checkpoint target for cancer immunotherapy","volume":"152","author":"Feng","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110951_b0100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 Immune Checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110951_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119150","article-title":"The role of CD47-SIRP\u03b1 immune checkpoint in tumor immune evasion and innate immunotherapy","volume":"273","author":"Li","year":"2021","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.intimp.2023.110951_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246229","article-title":"Cancer Therapy Targeting CD47\/SIRP\u03b1","volume":"13","author":"Dizman","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"13","key":"10.1016\/j.intimp.2023.110951_b0120","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.7150\/ijbs.60782","article-title":"CD47\/SIRP\u03b1 pathway mediates cancer immune escape and immunotherapy","volume":"17","author":"Jia","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.110951_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","article-title":"SIRPalpha-CD47 Immune Checkpoint Blockade in Anticancer Therapy","volume":"39","author":"Veillette","year":"2018","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110951_b0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2023.110951_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in Anti-Tumor Treatments Targeting the CD47\/SIRP\u03b1 Axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110951_b0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2023.110951_b0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/5584_2016_122","article-title":"Thrombosis and von Willebrand Factor","volume":"906","author":"Shahidi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"18","key":"10.1016\/j.intimp.2023.110951_b0150","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1074\/jbc.270.18.10822","article-title":"Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides","volume":"270","author":"Cruz","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0155","first-page":"17","article-title":"Von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.intimp.2023.110951_b0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3109\/1061186X.2016.1154563","article-title":"vwF A3-GPI modification of EPCs accelerates reendothelialization of injured vessels via collagen targeting in mice","volume":"24","author":"Tan","year":"2016","journal-title":"J. Drug Target."},{"issue":"5","key":"10.1016\/j.intimp.2023.110951_b0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","volume":"4","author":"Mansurov","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.intimp.2023.110951_b0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41551-020-0560-7","article-title":"Collagen-binding IL-12 inflames 'cold' tumours","volume":"4","author":"Scheller","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s40425-019-0812-9","article-title":"Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer","volume":"7","author":"Zhang","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2023.110951_b0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/19420862.2017.1409319","article-title":"Elimination of tumor by CD47\/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses","volume":"10","author":"Liu","year":"2018","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.intimp.2023.110951_b0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/2326-6066.CIR-16-0398","article-title":"Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer","volume":"5","author":"Zhang","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110951_b0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/carcin\/bgy041","article-title":"Disrupting CD47-SIRP\u03b1 axis alone or combined with autophagy depletion for the therapy of glioblastoma","volume":"39","author":"Zhang","year":"2018","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0195","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","article-title":"Collagen as a double-edged sword in tumor progression","volume":"35","author":"Fang","year":"2014","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110951_b0200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2013.03.005","article-title":"Vascular permeability changes involved in tumor metastasis","volume":"335","author":"Garc\u00eda-Rom\u00e1n","year":"2013","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.intimp.2023.110951_b0205","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/cas.14942","article-title":"Regulation of vascular permeability in cancer metastasis","volume":"112","author":"Tomita","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2023.110951_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867189","article-title":"The Era of Cytotoxic CD4 T Cells","volume":"13","author":"Cenerenti","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110951_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2023.110951_b0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2021.09.005","article-title":"The role of CD4 T cells in rejection of solid tumors","volume":"74","author":"Poncette","year":"2022","journal-title":"Curr. Opin. Immunol."},{"issue":"7900","key":"10.1016\/j.intimp.2023.110951_b0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41586-022-04439-0","article-title":"A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells","volume":"603","author":"Seung","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110951_b0230","article-title":"Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110951_b0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110951_b0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"7886","key":"10.1016\/j.intimp.2023.110951_b0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000519645","article-title":"Discoidin Domain Receptor 2: A New Target in Cancer","volume":"45","author":"Xu","year":"2022","journal-title":"Oncol Res Treat"},{"issue":"4","key":"10.1016\/j.intimp.2023.110951_b0255","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2023.110951_b0260","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.copbio.2021.02.003","article-title":"T cell metabolism in homeostasis and cancer immunity","volume":"68","author":"Wei","year":"2021","journal-title":"Curr. Opin. Biotechnol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:13:14Z","timestamp":1761588794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923012766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"alternative-id":["S1567576923012766"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110951","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A collagen-binding SIRP\u03b1Fc fusion protein for targeted cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110951"}}